Avalon BioVentures I, LP
SEC CIK 1873935 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | 10% | 6,926 | — | $45.78M | 8 | 2024-09-06 | 2024-09-27 |
Most active insiders at JANX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meyer Andrew Hollman | Chief Business Off | — | $736.7K |
| 2 | Campbell David Alan | Pres, CEO, Dir | — | $110.8K |
| 3 | Doyle Janeen Noel | Chief Corp, Bus. Dev. Ofcr | — | $56.9K |
| 4 | Dobek Maria | VP, Accounting | — | $49.0K |
| 5 | McIver Zachariah | Chief Medical Off | — | $37.3K |
| 6 | DiRaimondo Thomas | CSO | — | $34.4K |
| 7 | Winter Charles M. | Chief Technical Off | — | $33.0K |
| 8 | Go William | Chief Medical Off | — | — |
| 9 | Simson Jake | Dir | — | — |
| 10 | Hernday Natasha | Dir | — | — |
Avalon BioVentures I, LP made no open-market trades at JANX in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-09-30 | 2024-09-26+ | JANX | Janux Therapeutics, Inc. | Avalon BioVentures I, LP | 10% | S - Sale+OE | $46.96 | -167.3K | 2.88M | -5% | -$7.86M |
| DM | 2024-09-30 | 2024-09-26+ | JANX | Janux Therapeutics, Inc. | Avalon BioVentures I, LP | 10% | S - Sale+OE | $46.95 | -140.5K | 6,926 | -95% | -$6.60M |
| DM | 2024-09-30 | 2024-09-27+ | JANX | Janux Therapeutics, Inc. | Avalon BioVentures I, LP | 10% | M - OptEx | $18.07 | +2,671 | 8,752 | +44% | +$48.3K |
| MI | 2024-09-12 | 2024-09-10+ | JANX | Janux Therapeutics, Inc. | Avalon BioVentures I, LP | 10% | S - Sale | $46.89 | -247.4K | 3.18M | -7% | -$11.60M |
| M | 2024-09-12 | 2024-09-10+ | JANX | Janux Therapeutics, Inc. | Avalon BioVentures I, LP | 10% | S - Sale | $46.89 | -203.7K | 2.96M | -6% | -$9.55M |
| DM | 2024-09-10 | 2024-09-09 | JANX | Janux Therapeutics, Inc. | Avalon BioVentures I, LP | 10% | M - OptEx | $18.03 | +2,099 | 8,077 | +35% | +$37.8K |
| DM | 2024-09-10 | 2024-09-06+ | JANX | Janux Therapeutics, Inc. | Avalon BioVentures I, LP | 10% | S - Sale+OE | $42.01 | -110.5K | 3.16M | -3% | -$4.64M |
| DMI | 2024-09-10 | 2024-09-06 | JANX | Janux Therapeutics, Inc. | Avalon BioVentures I, LP | 10% | S - Sale+OE | $42.00 | -131.6K | 3.23M | -4% | -$5.53M |
Purchase Sale Sale after option exercise All abbreviations